However, we are seeing differences, for example with diabetes.
However, we are seeing differences, for example with diabetes.
17M just provides the baseline of "normal". Tons more data isn't needed to get that right. 170M wouldn't make a difference. I bet 1.7M wouldn't make a big difference either.
What we really need to know right now is how the Covid deaths behave. All that this offers is the 5,683 sample, but the title inflates it to emphasize the 17M. We need the 5,683 sample to be merged with other samples to reach 56,830, etc. That is the significant thing.
Sadly there will be more data as there are more deaths, and this team will be able to pull more analytics out. However 5,683 is a big enough sample size to find some interesting information on hazard rates.
For the team doing the analysis, plugging data analytics into 17 million primary care records is definitely a significant achievement. Medical records are intended for use by doctors and letting researchers into them has confidentiality issues. The process they followed was covered in the paper and seemed thorough.